Patent 7951794 was granted and assigned to Actelion on May, 2011 by the United States Patent and Trademark Office.
The invention relates to novel thiophene derivatives, their preparation and their use as pharmaceutically active compounds. Said compounds particularly act as immunosuppressive agents.